Global DNA And Gene Chip Market 2025–2029: Competitive Insights and Opportunities

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The DNA And Gene Chip Industry In 2025?

The scale of the DNA and gene chip sector has observed substantial expansion lately; projections indicate a rise from $8.19 billion in 2024 to $9.2 billion the following year, reflecting a compound annual growth rate (CAGR) of 12.2%. This upward trajectory during the past period stems from progress in genomic studies, the increasing adoption of tailored medical treatments, achievements related to the human genome project, acceleration in pharmaceutical research and creation, and breakthroughs in pinpointing disease indicators.

Anticipation surrounds the dna and gene chip market, which projects substantial future expansion, reaching a valuation of $15.13 billion by 2029, propelled by a compound annual growth rate (CAGR) of 13.3%; this upswing is largely fueled by progress in precision medicine, the widening scope of biomarker identification, the rise of individualized treatments, application within oncological studies, and augmented financial support for research endeavors, while key developments shaping this period involve technological leaps, novel product introductions, evolving regulatory standards and adherence, a heightened emphasis on addressing rare ailments, and ongoing efforts to decrease overall expenses.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

What Are The Key Drivers Of Growth In The DNA And Gene Chip Market?

The escalating need for methods to identify cancer in its nascent stages is a major impetus behind the expansion of the sector dealing with DNA and genes. Cancer, a comprehensive term for ailments that can manifest in nearly any bodily tissue or organ, arises when abnormal cells undergo uncontrolled proliferation, breaching adjacent tissues to infiltrate surrounding structures and subsequently metastasizing to distant sites. Within malignant cells, DNA and gene arrays serve as essential tools for quantifying how genes are expressed, mapping out the complete genetic and epigenetic context, and determining which genomic regulatory components are bound by the transcription factors associated with cancer. To illustrate the scale of this issue, the American Cancer Society, a non-profit health organization operating within the US, estimated for the year 2022 that the United States would see roughly 1.9 million new cancer diagnoses and an unfortunate total of 609,360 fatalities attributed to the disease. Consequently, this heightened imperative for soonest possible cancer identification fuels the advancement of the DNA and gene chip industry.

What Are The Different Segment Classifications Within The DNA And Gene Chip Market?

The dna and gene chipmarket covered in this report is segmented –

1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types

2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications

3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

Subsegments:

1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays

2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays

3) By Other Types: Single-Cell RNA Sequencing Chips, SNP (Single Nucleotide Polymorphism) Chips, Whole Genome Amplification Chips

What Are The Major Trends Driving The Growth Of The DNA And Gene Chip Market?

A growing emphasis on strategic alliances and collaborative ventures characterizes the current landscape of the DNA and gene chip market, with numerous sector participants actively seeking ways to augment their standing through such agreements. An illustrative example is the four-year strategic alliance forged in June 2022 between Avesthagen Limited, an Indian integrated systems biology organization, and Wipro Limited, an Indian information technology firm, whereby they are jointly undertaking genomic sequencing services for a project focused on assessing cancer risk via Next-Generation Sequencing profiling of cell-free DNA and RNA pertaining to lung cancer. Furthermore, in May 2022, Thermo Fisher Scientific, an American provider of analytical instrumentation, formed a partnership with the Qatar Genome Program (QGP), an entity within the Qatar Foundation (QF), with the objective of creating a specialized Axiom custom genotyping array tailored for pan-Arab populations, which leverages whole genome sequencing data sourced from nineteen Arab nations; this array, incorporating 800,000 genetic variations, is designed to significantly boost genomic research endeavors, particularly concerning ailments like diabetes, cardio-vascular conditions, autism, and cancer, thereby aligning with Qatar’s national objectives for enhanced population wellness and the progression of individualized medicine for individuals of Arab heritage globally, with Thermo Fisher’s Axiom microarray technology serving to expedite these precision medicine efforts.

Which Major Industry Participants Are Leading The DNA And Gene Chip Market Growth?

Major companies operating in the DNA and gene chip market are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Cepheid, Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Which Region Is Projected To Lead The DNA And Gene Chip Market During The Forecast Period?

North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The DNA And Gene Chip Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8205&type=smp

Browse Through More Reports Similar to the Global DNA And Gene Chip Market 2025, By The Business Research Company

Wireless Telecommunication Carrier Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wireless-telecommunication-carrier-global-market-report

5G Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/5g-services-global-market-report

5G Infrastructure Equipment Market 2025

https://www.thebusinessresearchcompany.com/report/5g-infrastructure-equipment-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795